Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-20-000072
Filing Date
2020-10-19
Accepted
2020-10-19 21:59:16
Documents
1
Period of Report
2020-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160315914206177.html 4  
1 FORM 4 wf-form4_160315914206177.xml 4 7530
  Complete submission text file 0001399529-20-000072.txt   8886
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Weissman James B (Reporting) CIK: 0001598480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 201247238